Trial intelligence / Profile preview

Aripiprazole for Drug-Induced Weight Gain in Bipolar Disorder

NCT00845988Phase 4Completed

Sponsor
Seoul National University Hospital
Start
Dec 2008
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aripiprazole in bipolar disorder (BD), drug-induced weight gain, sponsored by Seoul National University Hospital. Started Dec 2008; status: completed.

02

Drugs

aripiprazole
03

Conditions

bipolar disorder (BD)drug-induced weight gain

Beyond the preview

Go deeper on NCT00845988.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00845988.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call